Previous Page  8 / 26 Next Page
Information
Show Menu
Previous Page 8 / 26 Next Page
Page Background

6

“The greatest giftwe can give our patients is

mobility,” says Schoifet. Sometimes the gift is quite

literal. Last winter, two JRI surgeons, Gregory

Klingenstein, M.D., and KarimElsharkawy, M.D.,

volunteered their time, expertise, and JRI’s resources

to give free knee replacement surgeries to two

women throughOperationWalk 2015.

This nonprofit coalition of 55 volunteer orthopedic

surgeons from40 hospitals around the country

provides joint replacement surgeries to patients who

don’t qualify for government assistance, but can’t

afford surgery. One of the beneficiaries was 85-year-

oldHelen Richards, who received the quad-sparing

knee surgery, began rehabilitation the same day, and

was home only two days later.

“The surgery was an answered prayer,” says her

daughter CeliaQuitee. “I sawmymom suffering in

pain…but she had no insurance at all.”

Additional Virtua time and services were donated

every step of theway, including anesthesiology, pre-

and post-surgery care, physical therapy, and home

care. NowHelen can get to the gardening she’s been

wanting to do and fulfill her wish of returning home to

the Caribbean – demonstratingwhy the JRI has

become known as the institute of “I got my life back”

for somany patients fromall over the U.S.

JRI is not only a pioneer inminimally invasive joint

replacement surgery, but it is becoming nationally

renowned for its orthopedic research, which is

entirely funded by philanthropy. Its three studies

were selected from thousands of submitted

abstracts to be presented at highly regarded

orthopedics conferences.

Last November, one of these studies received the

Association of Hip and Knee Surgeons Clinical

Research Award for an outstanding clinical paper in

the field of hip and knee replacement. A six-person

teamof JRI researchers demonstrated that a traditional

Novocaine-type drug, which costs $16, is just as good

at relieving pain after knee replacement surgery as a

newdrug that costs $402 per dose.

“For Virtua to be awarded at this internationally-

recognized event speaks to our dedication to

science,” said Rajesh Jain, M.D., lead author of the

For Virtua to be awarded at this

internationally recognized event speaks

to our dedication to science.

‘‘

‘‘

Rajesh Jain, M.D.